Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Consulting agrmnt
Appointed director
MetaStat, Inc. (MTST) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/16/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "MetaStat Voluntarily Withdraws Listing on the OTCQB and Files Form 15 to Suspend its Reporting Obligations BOSTON, July 16, 2018 -- MetaStat, Inc. , a precision medicine company developing novel anti-metastatic drugs for the treatment of patients with aggressive cancer, today announced the Company is voluntarily deregistering its common stock under Section 12 of the Securities Exchange Act of 1934, as amended and suspending its reporting obligations under Section 15 of the Exchange Act by filing a Form 15 with the Securities and Exchange Commission on July 16, 2018. “After a thorough review of the benefits and risks associated with being a public company, management and the board of directors felt deregistering as an SEC reporting company is in the best interest of the Company and a..."
04/05/2018 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Senior Note",
"Form of Junior Note",
"Form of Note Warrant",
"Form of Note Purchase Agreement",
"Form of Exchange Agreement"
11/02/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/22/2017 8-K Quarterly results
08/07/2017 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
06/27/2017 8-K Form 8-K - Current report
06/19/2017 8-K Form 8-K - Current report
05/31/2017 8-K Form 8-K - Current report
05/08/2017 8-K Form 8-K - Current report
04/28/2017 8-K Form 8-K - Current report
02/16/2017 8-K Form 8-K - Current report
01/23/2017 8-K Form 8-K - Current report
11/03/2016 8-K Unregistered Sales of Equity Securities, Financial Statements and Exhibits
10/27/2016 8-K Form 8-K - Current report
10/17/2016 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Warrant",
"Series A-2 Convertible Preferred Stock Certificate of Designation",
"Form of Subscription Agreement",
"Form of Registration Rights Agreement"
10/06/2016 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "†",
"†"
09/09/2016 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "Form of Warrant",
"Form of Subscription Agreement",
"Form of Registration Rights Agreement"
09/07/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/31/2016 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Warrant",
"Form of OID Note Amendment"
06/14/2016 8-K Form 8-K - Current report
04/28/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/11/2016 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/10/2013 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Employment Agreement between the Company and Elizabeth Buck",
"Employment Agreement between the Company and Matthew O’Connor effective as of September 15, 2013",
"Agreement of Lease between the Company and Long Island High Technology Incubator, Inc.",
"###"
04/17/2013 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Advisory Agreement between the Company and Dr. David Epstein",
"MetaStat Appoints David Epstein, Ph.D. as Advisor to Lead Drug Discovery MONTCLAIR, N.J., April 15, 2013 /PRNewswire/ -- MetaStat, Inc. , a life science company focused on understanding and treating systemic metastasis, announced today the appointment of David Epstein, Ph.D. as Advisor for MetaStat’s Drug Discovery & Development efforts. In addition, MetaStat intends to appoint Dr. Epstein to MetaStat’s board of directors as soon as practicable. Dr. Epstein brings tremendous expertise to MetaStat at a pivotal time in the company’s evolution. His R & D career spans more than 15 years and he has held leadership positions in both the pharmaceutical and biotech industries. Most recently he was Senior Vice President and Chief Scientific Officer for OSI Pharmaceuticals, now a wholly owned subsid..."
03/01/2013 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Convertible Promissory Note",
"Form of Warrant",
"Form of Convertible Note and Warrant Purchase Agreement"
01/08/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "MetaStat, Inc. Announces Completion of 500 Patient Breast Cancer Trial"
12/26/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/20/2012 8-K Form 8-K - Current report
11/13/2012 8-K Form 8-K - Current report
08/13/2012 8-K/A Entered into consulting agreement
Docs: "EINSTEIN LICENSE AGREEMENT",
"CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “” OR OTHERWISE CLEARLY INDICATED. AN UNREDACTED VERSION OF THIS DOCUMENT HAS ALSO BEEN PROVIDED TO THE SECURITIES AND EXCHANGE COMMISSION. LICENSE AGREEMENT This Agreement is entered into as of January 3, 2012 , by and between Albert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University, a corporation organized and existing under the laws of the State of New York, having an office and place of business at 1300 Morris Park Avenue, Bronx, New York 10461 , and Metastat, Inc., a corporation organized and existing under the laws of the State of Delaware, having an office and place of business at 4 Autumnwood Court, The Woodlands, Texas 7738...",
"LICENSE AGREEMENT",
"Consent of MaloneBailey LLP, independent registered accountants",
"Audited Consolidated Financial Statements of MetaStat as of December 31, 2011 and 2010 and for the years ended December 31, 2011 and 2010"
07/13/2012 8-K/A Entered into consulting agreement
Docs: "EINSTEIN LICENSE AGREEMENT",
"LICENSE AGREEMENT",
"LICENSE AGREEMENT",
"Consent of MaloneBailey LLP, independent registered accountants",
"Audited Consolidated Financial Statements of MetaStat as of December 31, 2011 and 2010 and for the years ended December 31, 2011 and 2010"
05/25/2012 8-K/A Form 8-K - Current report [amend]
05/22/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "2012 Amended and Restated Omnibus Securities and Incentive Plan"
05/07/2012 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Warrant",
"Form of Securities Purchase Agreement",
"Form of Registration Rights Agreement"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy